Aster DM Healthcare Limited has announced the closure of its trading window for all designated persons and their immediate relatives. This closure will be effective from January 01, 2026, and will remain in effect until 48 hours after the announcement of the company's unaudited financial results for the quarter and nine months ended December 31, 2025 (both standalone and consolidated). This decision is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code for the prevention of insider trading. The company secretary and compliance officer, Hemish Purushottam, communicated this information to the stock exchanges.